Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncology

Basit Öğe Kaydı
dc.authoridduran, Ayse Ocak/0000-0002-1703-726X
dc.authoridakyol, murat/0000-0003-0886-3559
dc.authoridOzturk, Banu/0000-0003-0290-8787
dc.authoridKEFELI, UMUT/0000-0001-6126-5377
dc.authoridbenekli, mustafa/0000-0003-3184-4946
dc.authorwosidduran, Ayse Ocak/ABA-7090-2021
dc.authorwosidakyol, murat/AAV-5418-2021
dc.authorwosidOzturk, Banu/AAD-4358-2019
dc.authorwosidKaraoglu, Aziz/HKM-3509-2023
dc.authorwosidSevinc, Alper/KFQ-6440-2024
dc.authorwosidKEFELI, UMUT/V-6023-2017
dc.authorwosidoflazoglu, utku/HJP-4039-2023
dc.contributor.authorDemirci, Umut
dc.contributor.authorOflazoglu, Utku
dc.contributor.authorKodaz, Hilmi
dc.contributor.authorCiltas, Aydin
dc.contributor.authorKefeli, Umut
dc.contributor.authorAkyol, Murat
dc.contributor.authorOzturk, Banu
dc.date.accessioned2024-06-12T11:22:25Z
dc.date.available2024-06-12T11:22:25Z
dc.date.issued2014
dc.departmentTrakya Üniversitesien_US
dc.description50th Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- MAY 30-JUN 03, 2014 -- Chicago, ILen_US
dc.description.abstract[Abstract Not Available]en_US
dc.description.sponsorshipAmer Soc Clin Oncolen_US
dc.identifier.doi10.1200/jco.2014.32.15_suppl.e16094
dc.identifier.issn0732-183X
dc.identifier.issn1527-7755
dc.identifier.issue15en_US
dc.identifier.urihttps://doi.org/10.1200/jco.2014.32.15_suppl.e16094
dc.identifier.urihttps://hdl.handle.net/20.500.14551/25918
dc.identifier.volume32en_US
dc.identifier.wosWOS:000358613200846en_US
dc.identifier.wosqualityQ1en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofJournal Of Clinical Oncologyen_US
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subject[No Keywords]en_US
dc.titleAbiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (MCRPC) after docetaxel chemotherapy: Multicentric experience of Anatolian Society of Medical Oncologyen_US
dc.typeConference Objecten_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu